The stock market today has to contend with not-so-bad data out of China, but decidedly bad Retail Sales numbers on the home front. Investors will be looking for the market to build on last week�� record close as the Q2 earnings season gets into high gear and Bernanke provides further clarification on the 'Taper' issue in testimony before Congress later this week.
On the earnings front, Citigroup�� (C) better than expected report this morning following strong reports from J.P. Morgan (JPM) and Wells Fargo (WFC) on Friday sets us up the stage for a slew of banking sector earnings this week. Q2 earnings growth is resting solely on the banking sector and the group appers on track to come through on the promise.
China�� in-line second quarter GDP growth rate of 7.5% provides further confirmation of a decelerating trend in the world�� second largest economy, but it should ease some of the worst fears that suspected an even weaker showing. The country's new leadership team hasn�� shown any nervousness about the slowdown as they move the economy away from investment-led growth and more geared towards domestic consumption.
Hot Tech Companies To Own For 2015: Nuveen Preferred and Convertible Income Fund (JPC)
Nuveen Multi-Strategy Income & Growth Fund is a close-ended balanced mutual fund launched by Nuveen Investments Inc. The fund is co-managed by Nuveen Asset Management, Spectrum Asset Management, Tradewinds Global Investors, LLC, and Symphony Asset Management, LLC. It invests in the public equity and fixed income markets of the United States. The fund seeks to invest in the stocks of companies operating across diversified sectors. For the fixed income portfolio, it invests in the debt instruments, including high yield debt and senior loans. The fund benchmarks the performance of its portfolio against the Merrill Lynch Preferred Stock Hybrid Securities Index, Lehman Tier 1 Capital Securities Index, Merrill Lynch All U.S. Convertibles Index, and CSFB High Yield index. It was formerly known as Nuveen Preferred and Convertible Income Fund. Nuveen Multi-Strategy Income & Growth Fund was formed on March 26, 2003 and is domiciled in the United States.
Advisors' Opinion:- [By Douglas A. McIntyre]
J.C. Penney (NYSE: JPC) and the KMart and Sears divisions of Sears Holdings (NASDAQ: SHLD) are supposes to be the losers among large U.S. retailers. Their stores are too old, their brands too badly damaged, and their balance sheet too frail for either to do well in the white hot competition for holiday sales. However, their stock prices say otherwise, which means there is some expectation that they will outperform forecasts.
Top 10 Prefered Companies For 2014: Glacier Media Inc (GLMFF.PK)
Glacier Media Inc. (Glacier) is an information communications company focused on the provision of information and related services through print and digital media. Glacier has two segments: the newspaper and trade information markets and the business and professional information markets. The operations in the newspaper and trade information group include the Western Producer Publications and Farm Business Communications agricultural information group, Business In Vancouver Media Group, the JuneWarren-Nickle�� Energy Group, the Business Information Group, and the Glacier Newspaper Group. Its operations in the business and professional information group include Specialty Technical Publishers, CD-Pharma, Eco Log and a joint venture interest in Fundata. In November 2011, the Company acquired a 50% interest in InfoMine Inc. In November 2011, the Company acquired Canada�� Outdoor Shows Limited. In December 2011, it acquired Postmedia Network Inc.'s community newspapers in British Columbia. Advisors' Opinion:- [By Mike Arnold]
Shares of Glacier Media (GLMFF.PK)(GVC.TO) ("Glacier" or "the company") are cold product in this market of stocks, trading at decade lows after a summer sell-off. Famed value investor Walter Schloss preferred buying stocks not at 52-week lows, but at multi-year lows. If Mr. Schloss were here with us today, I suspect he'd be taking a look at Glacier shares.
Top 10 Prefered Companies For 2014: Harvest Natural Resources Inc (HNR)
Harvest Natural Resources, Inc., incorporated on September 9, 1988, is a petroleum exploration and production company. The Company is engaged in the exploration, development and production of properties in geological basins with proven active hydrocarbon systems. The Company holds interest in the Bolivarian Republic of Venezuela (Venezuela). The Company's Venezuelan interests are owned through Harvest-Vinccler Dutch Holding, B.V. Through HNR Energia, B.V. (HNR Energia), the Company indirectly owns 80% of Harvest Holding and its partner, Oil & Gas Technology Consultants (Netherlands) Cooperatie U.A., indirectly owns the remaining 20% interest of Harvest Holding. Harvest Holding owns, indirectly through wholly owned subsidiaries, a 40% of Petrodelta, S.A. (Petrodelta). The Company indirectly owns a net 32% interest in Petrodelta, and Venezolana de Inversiones y Construcciones Clerico, C.A. (Vinccler) indirectly owns 8%. Corporacion Venezolana del Petroleo S.A. (CVP) owns the remaining 60% of Petrodelta. Petroleos de Venezuela S.A. (PDVS) owns 100% of CVP. Harvest Holding has a direct controlling interest in Harvest Vinccler S.C.A. (Harvest Vinccler).
As of December 31, 2012, the Company's operations were located at Venezuela, Republic of Indonesia, Republic of Gabon, Sultanate of Oman and People's Republic of China. In Venezuela operations are through the Company's Petrodelta. In Republic of Indonesia (Indonesia) the operations are mainly onshore in West Sulawesi in Indonesia through the Budong PSC. The Company owns a 64.51% interest in the Budong PSC. In Republic of Gabon (Gabon) operations are offshore of Gabon through the Dussafu PSC. The Company has a 66.667% interest in the Dussafu PSC. The Company is the operator. In Sultanate of Oman (Oman) the operations are onshore in Oman through the exploration and production sharing agreement (EPSA) Al Ghubar / Qarn Alam license (Block 64 EPSA). The Company has an 80% interest in Block 64 EPSA. The Company is the operator. In People's Republic o! f China (China) the exploration acreage is offshore of China in the South China Sea through the Wab-21 Petroleum Contract (Wab-21). The Company has a 100% interest in the WAB-21 petroleum contract. The Company is the operator.
Petrodelta is engaged the exploration, production, gathering, transportation and storage of hydrocarbons from the Petrodelta Fields. As of December 31, 2012, there were 86 oil and natural gas producing wells and seven water injection wells in the Petrodelta Fields. As of December 31, 2012, there were 15 oil producing wells and four water injection wells in the Tucupita Field. As of December 31, 2012, there were 28 oil producing wells in the Temblador Field. At December 31, 2012, there were 17 oil producing wells and one water injection well in the El Salto field.
Advisors' Opinion:- [By Tess Stynes]
Harvest Natural Resources Inc.(HNR) agreed to sell all the company’s interest in Venezuela for $400 million in cash, as the energy company moves forward with its plans to sell itself.� Shares were up 24% at $4.89 premarket.
- [By Paul Ausick]
Harvest Natural Resources Inc. (NYSE: HNR) is up 17.3% at $4.62. The independent oil & gas company received an upgrade today based on the belief that company can sell some of its foreign assets.
- [By Lauren Pollock]
Among the companies with shares expected to actively trade in Monday’s session are Achillion Pharmaceuticals Inc.(ACHN), Active Network Inc.(ACTV) and Harvest Natural Resources Inc.(HNR)
Top 10 Prefered Companies For 2014: XenoPort Inc.(XNPT)
XenoPort, Inc., a biopharmaceutical company, focuses on developing and commercializing internally discovered product candidates that utilize the body?s natural nutrient transport mechanisms to enhance the therapeutic benefits of drugs. The company licenses its lead product candidate Gabapentin Enacarbil, a transported prodrug of gabapentin, to Astellas Pharma Inc. in Japan and five Asian countries, as well as to Glaxo Group Limited in the United States. Astellas Pharma Inc. filed new drug application for the approval of Gabapentin Enacarbil as a treatment for restless legs syndrome in Japan. The company also develops Arbaclofen Placarbil, which completed a Phase II clinical trial for the treatment of spasticity in patients with spinal cord injury. In addition, it develops Arbaclofen Placarbil for the treatment of gastroesophageal reflux disease. Further, the company develops XP21279, which is in Phase II clinical trial for the treatment of Parkinson?s disease; and XP2382 9, a novel prodrug of methylhydrogenfumarate that is in preclinical stage. It has strategic alliances with Astellas Pharma, Inc. and Glaxo Group Limited. The company was founded in 1999 and is based in Santa Clara, California.
Advisors' Opinion:- [By CRWE]
XenoPort, Inc. (Nasdaq:XNPT) reported that it has submitted an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) to begin clinical studies of XP23829 as a potential treatment for relapsing-remitting multiple sclerosis (RRMS).
- [By Max Macaluso, Ph.D.]
Treatments for RLS
While a better understanding of RLS and its long-term impact on health are needed, there are FDA-approved drugs available to treat the symptoms of this disorder. GlaxoSmithKline (NYSE: GSK ) brought a RLS drug, Requip, to market eight years ago, and the drug was also approved for Parkinson's disease. Total sales of the medication have been falling in recent years due to generic competition and reached only 164 million pounds ($257.5 million) in 2012. Until recently, GSK also had a second RLS drug called Horizant in collaboration with biotech company XenoPort (NASDAQ: XNPT ) . GSK recently handed the rights to the drug back to XenoPort after sales failed to meet its expectations, and the biotech is now commercializing the drug alone. - [By Sean Williams]
Shareholders of XenoPort (NASDAQ: XNPT ) are also glad for the long weekend after their stock tumbled this week following disappointing late-stage results for Arbaclofen Placarbil, or AP. Aimed at treating spasticity in patients with multiple sclerosis, AP was unsuccessful in delivering a statistically significant benefit compared to the placebo. XenoPort's management noted that the company plans to cease development of AP and instead focus on the commercial development of recently approved restless leg syndrome drug Horizant, and its remaining clinical pipeline.
Top 10 Prefered Companies For 2014: JMP Group Inc (JMP)
JMP Group Inc., through its subsidiaries, operates as an investment banking, asset management, and corporate credit management company in the United States. The company provides various investment banking products and services, such as capital raising, mergers and acquisitions transaction, and other strategic advisory services to corporate clients. It also offers sales and trading services, which include distributing equity research products, communicating proprietary investment recommendations, executing equity trades on behalf of institutional clients, and marketing the securities of companies, as well as related brokerage services to institutional investors. In addition, the company provides proprietary equity research in five industries, including consumer, financial services, healthcare, real estate, and technology industries. Further, it provides asset management products and services to institutional investors, and high net-worth individuals; and involves in the man agement of collateralized loan obligations. JMP Group Inc. was founded in 1999 and is headquartered in San Francisco, California with additional offices in New York, New York; Boston, Massachusetts; Chicago, Illinois; and Alpharetta, Georgia.
Advisors' Opinion:- [By Marc Bastow]
Full-service investment banking, asset management and corporate credit management firm JMP Group (JMP) raised its quarterly dividend 13% to 4.5 cents per share, payable April 11 to shareholders of record as of March 28.
JMP Dividend Yield: 2.41%
Top 10 Prefered Companies For 2014: MGT Capital Investments Inc (MGT)
MGT Capital Investments, Inc (MGT), incorporated in 1977, is a holding company. As of December 31, 2011, the Company was analyzing potential acquisition opportunities in healthcare marketing and technology, as well as various intellectual property assets. The Company has a controlling interest in Medicsight ltd (Medicsight) and its subsidiaries Medicsight, Inc., Medicsight KK (Japan), Medicsight Pty Limited (Australia), Medicsight FZE (UAE), MedicEndo Limited (UAE), MedicCO2lon Limited (UAE) and Medicsight UK Limited (UK). The Company also have wholly owned subsidiaries MGT Capital Investments (UK) Limited, MGT Investments (Gibraltar) Limited, and Medicsight. Medicsight and its wholly owned subsidiaries is a medical technology company focusing on medical imaging software development and medical hardware devices. On March 29, 2011 the Company disposed of its 49% holding in Moneygate Group Limited (Moneygate). In September 2013, MGT Capital Investments, Inc MGT Interactive, LLC acquired certain assets from Gioia Systems LLC.
Medicsight�� core technology is the ColonCAD algorithm that is integrated (using application protocol interface (API) technology) into visualization workstations for radiologists to use when reviewing a patient�� colon computer tomography (CT) scan data. The computer-aided detection (CAD) algorithm assists the radiologist as they search for polyps in the CT scan image data. The radiologist uses the visualization software to review the patient�� CT scan images on the screen and searches for polyps (potentially pre-cancerous lesions on the wall of the colon). After a full review, the radiologist then activates the Medicsight ColonCAD software, which immediately displays CAD marks on the images, drawing the radiologist�� attention to potential polyps and other regions of interest. The radiologist then assesses each marked region in order to make the final decision as to the presence or absence of a polyp.
In addition to the computer aided detection so! ftware applications, Medicsight has developed an automated carbon dioxide (CO2) insufflation device, MedicCO2LON. A patient undergoing a CT colon scan requires the colon to be insufflated (distended) with either CO2 gas or room air administered prior to the acquisition of their CT colonography images. MedicCO2LON is designed to provide insufflation, for the acquisition of images from the CT colonography examination.
The Company competes with GE, Hitachi, Philips, Siemens and Toshiba.
Advisors' Opinion:- [By Markman Advisors]
Public companies leveraging their patent portfolios, (aka "patent plays"), are getting the market's attention. Companies such as Vringo (VRNG), ParkerVision (PRKR), MGT Capital (MGT), Worlds Inc. (WDDD.OB) and others have presented trading opportunities due to their volatility while retaining the chance for a big payoff to those investors who stay the course. Yet there exist viable patent plays that are still undiscovered. Some of these so called "plays," which are not getting enough attention, are actually real companies making and selling real products or services in contrast to pure patent monetization companies. Some known examples are Single Touch Interactive (SITO.OB) and Blue Calypso (BCYP.OB). This article is focused on another one of these patent plays, On Track Innovations Ltd. (OTIV).
Top 10 Prefered Companies For 2014: Aviva PLC (AVV)
Aviva plc (Aviva) is an insurance group engaged in provision of products and services, such as long-term insurance and savings, fund management and general insurance. Aviva provides long-term insurance and savings, general and health insurance, and fund management products and services. Its business is managed on four geographic regions: United Kingdom, Europe, North America and Asia Pacific. The four regions, together with Aviva Investors, function as six operating segments. The UK region is split into the UK Life and UK General Insurance segments, which undertake long-term insurance and savings business and general insurance, respectively. In April 2013, it transferred its holding in Spanish joint venture Aseval to Bankia. In October 2013, Aviva sold Aviva USA Corporation to Athene Holding Ltd. Effective December 12, 2013, Redefine International Plc, a unit of Redefine Properties Ltd, acquired Weston Favell Shopping Centre from Aviva Commercial Finance Ltd, a unit of Aviva plc. Advisors' Opinion:- [By Namitha Jagadeesh]
Kabel Deutschland Holding AG rose to a record after getting an offer from Liberty Global Plc. Aveva Group Plc (AVV) jumped 5.4 percent as Citigroup Inc. upgraded the shares. Danske Bank A/S (DANSKE) dropped 6.1 percent after Denmark�� financial regulator ordered it to increase its risk-weighted assets. Royal Imtech NV fell to the lowest price since 2004 after posting a first-quarter loss on costs relating to a fraud investigation.
No comments:
Post a Comment